{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_001033545.1:c.89C>T",
          "cDNA Change": {
            "transcript": "NM_001033545.1",
            "ref": "C",
            "alt": "T",
            "position": "89"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P variant"
        },
        {
          "HGVS": "NM_001033545.1:c.137A>G",
          "cDNA Change": {
            "transcript": "NM_001033545.1",
            "ref": "A",
            "alt": "G",
            "position": "137"
          },
          "Protein Change": {
            "ref": "E",
            "alt": "K",
            "position": "46"
          },
          "Description in input context": "E46K variant"
        },
        {
          "HGVS": "NM_001033545.1:c.158C>A",
          "cDNA Change": {
            "transcript": "NM_001033545.1",
            "ref": "C",
            "alt": "A",
            "position": "158"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "T",
            "position": "53"
          },
          "Description in input context": "A53T variant"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005029"
  },
  "Experiment Method": [
    {
      "Assay Method": "Solution NMR",
      "Material used": {
        "Material Source": "N.D.",
        "Material Name": "Recombinant α-synuclein variants",
        "Description": "NMR analysis of phospholipid binding properties of α-synuclein variants (A30P, E46K, A53T) compared to wild-type."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_001033545.1:c.89C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Decreased lipid affinity",
          "Result Description": "A30P variant showed decreased phospholipid binding affinity compared to wild-type."
        },
        {
          "Variant": "NM_001033545.1:c.137A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Increased lipid affinity",
          "Result Description": "E46K variant exhibited increased phospholipid binding affinity relative to wild-type."
        },
        {
          "Variant": "NM_001033545.1:c.158C>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Comparable lipid affinity",
          "Result Description": "A53T variant demonstrated phospholipid affinity comparable to wild-type."
        },
        {
          "Variant": "N.D.",
          "Conclusion": "N.D.",
          "Molecular Effect": "Elevated SL1 binding mode",
          "Result Description": "All variants (A30P, E46K, A53T) showed elevated population of the SL1 binding mode compared to wild-type."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type α-synuclein used as reference for comparison."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phospholipid binding affinity and SL1 binding mode population matching wild-type α-synuclein",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phospholipid binding affinity significantly different from wild-type or elevated SL1 binding mode population",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}